Moses Goddard

ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA.

Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ.

MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Wednesday Management LLC (Valhalla Partners) is a venture capital firm founded in 2002. The firm is headquartered in Vienna, Virginia.

Asia Renal Care Pte Ltd. provides kidney dialysis and related services in the Asia-Pacific region. It provides hem dialysis treatments to patients who suffer from end-stage renal diseases. The firm owns and operates dialysis facilities in Taiwan, Philippines, Japan, Malaysia and Korea. The company was founded in 1997 and is headquartered in Singapore.

Intracel Holdings Corp. engages in the development of vaccines and diagnostic products for cancer and infectious diseases. The company was founded in 2013 and is headquartered in Frederick, MD.

CDP Group Ltd. is a holding company that provides human resource outsourcing services. It offers products such as payroll and benefit outsourcing, SaaS human resource-demand, shared services, recruitment, expatriate, and other value added services. The company was founded by Wayne Wang and Wei Lu on October 21, 2004, and is headquartered in Shanghai, China.

Eight Roads Capital Advisors (Hong Kong) Ltd(Eight Roads Capital) is a venture capital firm founded in 1900. Headquartered in Hong Kong.

Protos LLC is founded in 1999 by Thomas H. Grant. It is headquartered in Massachusetts, US.

Meakem Becker Venture Capital LLC (MBVC) is a venture capital firm founded in 2002 by David J. Becker and Glen T. Meakem. The firm is headquartered in Sewickley, Pennsylvania.

Stage 1 Ventures LLC (Stage 1 Ventures) is a venture capital firm founded in 2006 by David William Baum. The firm is headquartered in Miami, Florida.

iSoftstone, Inc. provides information technology services and solutions. The company was founded on September 30, 2008 and is headquartered in Kirkland, WA.

BMI Asia, Inc. provides business management initiatives services. The private company is based in Shanghai, China. The Chinese company was founded by Ye Sha.

Eight Roads Ventures India (Eight Roads Ventures) is a private equity/venture capital firm founded in 2007. The firm is headquartered in Karnataka, India.

Part of Alibaba Group Holding Ltd., Alibaba.com China Ltd. provides software, technology, online business-to-business and e-commerce services.

Eight Roads Ventures Japan is a Private Equity/Venture Capital firm, a subsidiary of FIL Ltd. founded in 2008. Eight Roads Ventures Japan is headquartered in Tokyo.

CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA.

ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA.

Invetx, Inc. operates as a veterinary therapeutics company. It focuses on biopharmaceuticals that bring human biotechnology to animal health. The company is headquartered in Boston, MA.

Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research.

Geneception, Inc. provides healthcare services. The company is headquartered in Cambridge, MA.

Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer.

Part of ElevateBio LLC, LifeEDIT Therapeutics, Inc. is a next-generation genome editing company that has built a highly innovative platform with one of the world's largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The company offers gene editing tools with higher fidelity, novel functionality, reduced immune response risk, and easier delivery. LifeEDIT has a large and diverse library of RGNs, including type II and type V systems that encompass knock-out and knock-in capabilities, transcriptional regulation, and base editing when coupled with one of their proprietary deaminases. The company's nuclease collection has a broad range of protospacer adjacent motifs (PAMs), offering unprecedented access to genomes. LifeEDIT is headquartered in Morrisville, NC. The CEO of the company is Mitchell H. Finer. LifeEDIT Therapeutics was acquired by ElevateBio LLC from AgBiome Delta LLC on October 27, 2021.

Skyline Therapeutics (Hong Kong) Ltd. is a Chinese gene therapy company founded in 2018. The company is fully integrated and focused on discovering, developing, and delivering innovative therapies.

Tabby Therapeutics Ltd. develops therapeutic drugs. The company is based in Ness Ziona, Israel. The Israeli company was founded in 2021 by Adi Barzel, Alessio D. Nahmad.